Anyone have any idea where the company is regarding colorectal and other cancers? This appears to have fallen off the radar, but were they not supposed to be giving an update around now about Gan. in other cancers?
STA9090: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Estimated Enrollment: 24
Study Start Date: May 2012
Estimated Study Completion Date: November 2014
Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)